The Peanut Patch Revolution: Is Epicutaneous Immunotherapy the Future of Peanut Allergy Treatment in Children?

Could a simple skin patch transform the treatment of peanut allergy in young children?In this episode of Hope & Histamine: The Paediatric Allergy Podcast, we explore the latest evidence on epicutaneous immunotherapy (EPIT)—also known as the peanut patch—for toddlers and children with peanut allergy.Drawing on findings from the EPITOPE and EPOPEX studies, we examine how peanut patch therapy works, its long-term effectiveness and safety, and whether it can increase the amount of peanut a child can tolerate. We also discuss its potential to reduce the risk of allergic reactions from accidental exposure to packaged foods and consider how well EPIT works in children who also have atopic conditions such as eczema, asthma and allergic rhinitis.Can epicutaneous immunotherapy offer families meaningful protection while avoiding some of the challenges associated with oral immunotherapy? Could the peanut patch become part of routine childhood peanut allergy treatment?Join us as we translate the emerging research into clear, practical information for parents, clinicians and everyone interested in the future of paediatric food allergy care.Sources:Burks, A., Sindher, S., Wang, J., O'Sullivan, M., Du Toit, G., Kim, E., Bois, T. and Greenhawt, M., 2022. EPITOPE study results: Phase 3, randomized, double-blind, placebo-controlled study of epicutaneous immunotherapy in peanut-allergic toddlers [Abstract]. Annals of Allergy, Asthma & Immunology, 129(5 Supplement), p. S12.Greenhawt, M., Wang, J., DuToit, G., O’Sullivan, M., Brown-Whitehorn, T., Bois, T., Bee, K., Green, T., Sampson, H. and Burks, A., 2025. Long-term efficacy and safety of epicutaneous immunotherapy in peanut-allergic toddlers: EPOPEX end of study results [Abstract]. Annals of Allergy, Asthma & Immunology, 135(5 Supplement), p. S10. Remington, B.C., Krone, T., Kim, E.H., Bird, J.A., Green, T.D., Lack, G., Fleischer, D.M. and Koppelman, S.J., 2019. Estimated risk reduction to packaged food reactions by epicutaneous immunotherapy (EPIT) for peanut allergy. Annals of Allergy, Asthma & Immunology, 123(5), pp. 488-493. Scurlock, A.M., Fleischer, D.M., Du Toit, G., Arends, N.J.T., Pongracic, J.A., Trujillo, J., Turner, P., Vogelberg, C., Bee, K.J., Green, T.D., Meney, J., Bois, T., Campbell, D.E., Sampson, H.A. and Burks, A.W., 2025. Efficacy and safety of epicutaneous immunotherapy in children with peanut allergy with atopic comorbidities. Annals of Allergy, Asthma & Immunology, 135(2), pp. 203-210.🎧 Listen now on Apple Podcasts, Spotify, Amazon Music, and YouTubeDisclaimer: The information shared in this podcast and on this website is not intended to replace professional medical advice, diagnosis, or treatment. Always consult your doctor or a qualified healthcare provider with any questions you may have about a medical condition. Please don't ignore or delay seeking medical advice based on content from this podcast or website.Buy me a coffee: https://coff.ee/goodlifecreationsSend us Fan MailSupport the showBrought to you by - Goodlife Creations (2026). Music by - Denys Kyshchuk from Pixabay.